Literature DB >> 16519749

Antibacterial effects of human group IIA and group XIIA phospholipase A2 against Helicobacter pylori in vitro.

Heikki T Huhtinen1, Juha O Grönroos, Juha M Grönroos, Jaakko Uksila, Michael H Gelb, Timo J Nevalainen, V Jukka O Laine.   

Abstract

Group IIA phospholipase A2 (PLA2-IIA) is an enzyme which has important roles in inflammation and infection. Recently, a novel human secretory PLA2 called group XIIA PLA2 (PLA2-XIIA) has been identified. Both PLA2-IIA and PLA2-XIIA are bactericidal against Gram-positive bacteria like many other secretory PLA2s. However, PLA2-XIIA is the only known PLA2 displaying significant bactericidal activity against the Gram-negative bacterium Escherichia coli. We examined the antibacterial properties of recombinant human PLA2-IIA and PLA2-XIIA against Helicobacter pylori, a Gram-negative bacterium, in vitro. PLA2-IIA was not bactericidal against H. pylori, whereas PLA2-XIIA effectively killed H. pylori at a concentration of 50 microg/ml but was not bactericidal at concentrations of 0.5 microg/ml and 5 microg/ml.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16519749     DOI: 10.1111/j.1600-0463.2006.apm_330.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  12 in total

1.  Variation near complement factor I is associated with risk of advanced AMD.

Authors:  Jesen A Fagerness; Julian B Maller; Benjamin M Neale; Robyn C Reynolds; Mark J Daly; Johanna M Seddon
Journal:  Eur J Hum Genet       Date:  2008-08-06       Impact factor: 4.246

2.  Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU.

Authors:  Vincent T Lee; Stefan Pukatzki; Hiromi Sato; Eriya Kikawada; Anastasia A Kazimirova; Jin Huang; Xiaohua Li; Jonathan P Arm; Dara W Frank; Stephen Lory
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

3.  Expression of secreted phospholipase A2-Group IIA correlates with prognosis of gastric adenocarcinoma.

Authors:  Chengwei Zhang; Haipeng Yu; Haiyan Xu; Lanlan Yang
Journal:  Oncol Lett       Date:  2015-09-21       Impact factor: 2.967

4.  Role of polymorphic variants as genetic modulators of infection in neonatal sepsis.

Authors:  Asmaa Abu-Maziad; Kendra Schaa; Edward F Bell; John M Dagle; Margaret Cooper; Mary L Marazita; Jeffrey C Murray
Journal:  Pediatr Res       Date:  2010-10       Impact factor: 3.756

5.  A new era of secreted phospholipase A₂.

Authors:  Makoto Murakami; Hiroyasu Sato; Yoshimi Miki; Kei Yamamoto; Yoshitaka Taketomi
Journal:  J Lipid Res       Date:  2015-03-24       Impact factor: 5.922

6.  Kinetic evaluation of cell membrane hydrolysis during apoptosis by human isoforms of secretory phospholipase A2.

Authors:  Erin D Olson; Jennifer Nelson; Katalyn Griffith; Thaothanh Nguyen; Michael Streeter; Heather A Wilson-Ashworth; Michael H Gelb; Allan M Judd; John D Bell
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

7.  Distribution of secretory phospholipase A2 XIIA in the brain and its role in lipid metabolism and cognition.

Authors:  Sze-Min Ee; Yew-Long Lo; Guanghou Shui; Markus R Wenk; Eun-Joo Shin; Hyoung-Chun Kim; Wei-Yi Ong
Journal:  Mol Neurobiol       Date:  2014-01-25       Impact factor: 5.590

8.  Secreted phospholipase A2 is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meconium aspiration syndrome.

Authors:  Roberto Romero; Bo Hyun Yoon; Piya Chaemsaithong; Josef Cortez; Chan-Wook Park; Rogelio Gonzalez; Ernesto Behnke; Sonia S Hassan; Francesca Gotsch; Lami Yeo; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-01-06

9.  Characterization of serum phospholipase a(2) activity in three diverse species of west african crocodiles.

Authors:  Mark Merchant; Kate Juneau; Jared Gemillion; Rodolfo Falconi; Aaron Doucet; Matthew H Shirley
Journal:  Biochem Res Int       Date:  2011-10-29

Review 10.  Group IID, IIE, IIF and III secreted phospholipase A2s.

Authors:  Makoto Murakami; Yoshimi Miki; Hiroyasu Sato; Remi Murase; Yoshitaka Taketomi; Kei Yamamoto
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-31       Impact factor: 4.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.